Investigating pRophylactic utErosacral suspension AT Total lAparoscopiC Hysterectomy for patient outcomes and risk of prolapse occurrence - a randomised controlled trial (REATTACH)

Townsville University Hospital0 个研究点目标入组 66 人开始时间: 2022年7月5日最近更新: 2022年8月9日

试验速览

暂无简介。

•Patients must be 18 years of age or older
•Patients must be able to provide informed consent
•Preoperative inclusion criteria include: C point not past the hymenal remnant, i.e. C point at point 0 at Valsalva
•Patients with no prolapse symptoms
•A Pelvic ultrasound scan (USS) in the last 6 months from booking of procedure to show that size of uterus is less than or equal to 300cc

•Women undergoing a total laparoscopic hysterectomy for malignancy
•Women with a history of pre-existing pelvic organ prolapse, patients with cervical apical descent past the hymen, grade 2 uterocervical pelvic organ prolapse will be excluded
•Women with serious medical conditions who are unable to perform a Valsalva manoeuvre
•Non-English-speaking patients (unless access to a qualified interpreter is available during the full duration of the study)
•Size of uterus on ultrasound scan greater than 300cc
•Age greater than 75 years old
•BMI greater than 45
•Pathology obliterating the pouch of Douglas
•Stage 4 endometriosis
•Anticipated geographic relocation within the first 12 months following surgery

发起方

Townsville University Hospital